Page last updated: 2024-12-06

indorenate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID71987
CHEMBL ID414636
SCHEMBL ID10080621
MeSH IDM0104171
PubMed CID71986
CHEMBL ID1203765
SCHEMBL ID10566582
MeSH IDM0104171

Synonyms (58)

Synonym
indorenatum
indorenate [inn]
unii-av9l041qa4
methyl (+-)-alpha-(aminomethyl)-5-methoxy-3-indolylacetat
av9l041qa4 ,
indorenato
methyl (+-)-alpha-(aminomethyl)-5-methoxyindol-3-acetat
indorenate
PDSP1_000011
PDSP2_000011
PDSP2_001485
1h-indole-3-acetic acid, alpha-(aminomethyl)-5-methoxy-, methyl ester
indorenatum [inn-latin]
indorenato [inn-spanish]
PDSP1_001501
methyl 3-amino-2-(5-methoxy-1h-indol-3-yl)propanoate
73758-06-2
CHEMBL414636
1h-indole-3-acetic acid, .alpha.-(aminomethyl)-5-methoxy-, methyl ester
methyl (+/-)-.alpha.-(aminomethyl)-5-methoxyindole-3-acetate
DTXSID2048400
NCGC00161405-02
SCHEMBL10080621
Q6026626
indorenate hcl
CHEMBL1203765
1h-indole-3-acetic acid, alpha-(aminomethyl)-5-methoxy-, methyl ester, monohydrochloride, (+-)-
indorenate hydrochloride [usan]
1h-indole-3-acetic acid, alpha-(aminomethyl)-5-methoxy-, methyl ester, monohydrochloride
methyl (+-)-alpha-(aminomethyl)-5-methoxyindole-3-acetate monohydrochloride
tr 3369
indorenate hydrochloride (usan)
72318-55-9
D04533
indorenate hydrochloride
tr-3369
NCGC00161405-01
methyl 3-amino-2-(5-methoxy-1h-indol-3-yl)propanoate hydrochloride ,
dtxsid5046306 ,
tox21_111994
dtxcid3026306
cas-72318-55-9
860o06cjwz ,
unii-860o06cjwz
clorhidrato de 5-metoxitriptamina beta-metilcarboxilato
clorhidrato de 5-metoxitriptamina beta-metilcarboxilato [spanish]
NL33310000
niosh/nl3331000
methyl (+-)-alpha-(aminoethyl)-5-methoxyindole-3-acetate monohydrochloride
methyl alpha-(aminomethyl)-5-methoxy-1h-indole-3-acetate monohydrochloride
5-methoxytryptamine, beta-methylcarboxylate hydrochloride
1h-indole-3-acetic acid, .alpha.-(aminomethyl)-5-methoxy-, methyl ester, monohydrochloride, (+/-)-
methyl (+/-)-.alpha.-(aminomethyl)-5-methoxyindole-3-acetate monohydrochloride
SCHEMBL10566582
indorenate (hydrochloride)
Q27269685
methyl3-amino-2-(5-methoxy-1h-indol-3-yl)propanoatehydrochloride
methyl 3-amino-2-(5-methoxy-1h-indol-3-yl)propanoate;hydrochloride

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
"0 mg/kg) reduced the stimulus properties of INDO to 25% with a clear dose-response relationship."( Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats.
Sánchez, H; Velázquez-Martínez, DN, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
phosphopantetheinyl transferaseBacillus subtilisPotency89.12510.141337.9142100.0000AID1490
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency26.83700.01237.983543.2770AID1645841
cytochrome P450 2D6Homo sapiens (human)Potency0.00600.00108.379861.1304AID1645840
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency0.00230.005612.367736.1254AID624032
aryl hydrocarbon receptorHomo sapiens (human)Potency14.33430.000723.06741,258.9301AID743085; AID743122
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID171127Antihypertensive activity in renal hypertensive rats 8 hr after oral administration (10 mg/Kg)1982Journal of medicinal chemistry, Jun, Volume: 25, Issue:6
Tryptophan analogues. 1. Synthesis and antihypertensive activity of positional isomers.
AID171126Antihypertensive activity in renal hypertensive rats 6 hr after oral administration (10 mg/Kg)1982Journal of medicinal chemistry, Jun, Volume: 25, Issue:6
Tryptophan analogues. 1. Synthesis and antihypertensive activity of positional isomers.
AID170989Antihypertensive activity in renal hypertensive rats 1 hr after oral administration (10 mg/Kg)1982Journal of medicinal chemistry, Jun, Volume: 25, Issue:6
Tryptophan analogues. 1. Synthesis and antihypertensive activity of positional isomers.
AID170991Antihypertensive activity in renal hypertensive rats 4 hr after oral administration (10 mg/Kg)1982Journal of medicinal chemistry, Jun, Volume: 25, Issue:6
Tryptophan analogues. 1. Synthesis and antihypertensive activity of positional isomers.
AID170990Antihypertensive activity in renal hypertensive rats 2 hr after oral administration (10 mg/Kg)1982Journal of medicinal chemistry, Jun, Volume: 25, Issue:6
Tryptophan analogues. 1. Synthesis and antihypertensive activity of positional isomers.
AID50196Change in blood pressure in normotensive anesthetized cat.1982Journal of medicinal chemistry, Jun, Volume: 25, Issue:6
Tryptophan analogues. 1. Synthesis and antihypertensive activity of positional isomers.
AID50198Decrease in blood pressure in normotensive anesthetized cat at dose 10 mg/Kg iv1982Journal of medicinal chemistry, Jun, Volume: 25, Issue:6
Tryptophan analogues. 1. Synthesis and antihypertensive activity of positional isomers.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (45)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (11.11)18.7374
1990's22 (48.89)18.2507
2000's13 (28.89)29.6817
2010's2 (4.44)24.3611
2020's3 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.29 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other43 (100.00%)84.16%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]